In the private sector, Osborn has been a senior executive for several prominent firms in life sciences and healthcare, including biopharmaceutical companies Cephalon, Dendreon and Onyx Pharmaceuticals, and the cancer services company US Oncology, Inc. (which now operates as part of McKesson Specialty Health, a unit of McKesson Corporation).
Dendreon |